Tag: performance

LONDON, June 25, 2026 /PRNewswire/ -- BPC has been recognised with three prestigious titles at the Global Brand Awards 2026, organised by Global Brands Magazine...

DEMIRE is expanding its ESG database to cover almost its entire portfolio and is continuing to drive forward decarbonization

KNL, owned by Telenor Group, has been appointed as an approved supplier on the United Kingdom's Tactical Communication Systems Framework

BEIJING, June 25, 2026 /PRNewswire/ -- Chinese President Xi Jinping has called for solid measures to advance the modernization of agriculture and rural areas,...

CHENGDU, China, June 25, 2026 /PRNewswire/ -- On June 23, 2026, C-Ray Therapeutics (Chengdu) Co., Ltd. ("C-Ray Therapeutics") completed on-site inspections conducted by a panel...

DALLAS, June 24, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced the pricing of an underwritten public offering of 32,500,001 shares of its common stock at a price to the public of $6.00 per share and, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase 833,333 shares of its common stock at an offering price of $5.999 per pre-funded warrant, in each case before underwriting discounts and commissions. All of the securities are being offered by Taysha. In addition, Taysha has granted the underwriters a 30-day option to purchase up to an additional 5,000,000 shares of common stock at the public offering price, less underwriting discounts and commissions. The gross proceeds from the offering to Taysha are expected to be approximately $200.0 million, before deducting underwriting discounts and commissions and other offering expenses, excluding any exercise of the underwriters’ option to purchase additional shares. The offering is expected to close on or about June 26, 2026, subject to customary closing conditions.

HONG KONG, June 25, 2026 (GLOBE NEWSWIRE) -- Guest Supply today announced a licensing agreement with RODA to manufacture and distribute RODA-branded skincare and personal care products across Asia Pacific for the hotel sector.

RALEIGH, N.C., June 24, 2026 /PRNewswire/ -- Cardinal Infrastructure Group, Inc. (the "Company" or "Cardinal") (Nasdaq: CDNL) today announced the pricing of an upsized...

Global market projected to grow at a CAGR of 13.5% from 2026 to 2033 as pharmaceutical, food, and healthcare industries increasingly rely on advanced...

Hosted free by Pharmacy Stars on June 25, eight Camino Compass faculty, led by Principal Faculty Jocelyn Freimuth, PharmD, MBA, BCSCP, will put 64...

Recognition highlights advanced manufacturing capabilities at Rockwell's Singapore facility and the company's role in scaling AI-driven transformationSINGAPORE, June 25, 2026 /PRNewswire/ -- Rockwell Automation,...